Approval · Notice of Compliance 31747 · 2023
IMOVANE: Notice of Compliance 31747
Issued September 29, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31747
- Date
- September 29, 2023
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the Product Monograph to remove any text involving the 5 mg tablet
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMOVANE | Not yet assigned | — |
Medicinal ingredients
- ZOPICLONE 7.5 MG per TAB